Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-30 IGKV1-39 IGKV1-17	4.69e-06	190	206	11	GO:0003823
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RABEP2 TRIO IQSEC2 GCGR DENND2B ARHGAP22 DENND4B DENND6B HERC1 ACAP3 TNS3 RANBP3 ASAP3 ARHGAP17 ARHGAP39 ARHGEF10	7.78e-05	507	206	16	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RABEP2 TRIO IQSEC2 GCGR DENND2B ARHGAP22 DENND4B DENND6B HERC1 ACAP3 TNS3 RANBP3 ASAP3 ARHGAP17 ARHGAP39 ARHGEF10	7.78e-05	507	206	16	GO:0030695
GeneOntologyBiologicalProcess	immunoglobulin production	IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 TCF3	3.48e-29	241	225	35	GO:0002377
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 TCF3	1.52e-21	403	225	35	GO:0002440
GeneOntologyBiologicalProcess	adaptive immune response	FBXO38 IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 ZBTB7B ASCL2 IL21R	7.34e-14	838	225	38	GO:0002250
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	1.41e-33	166	229	34	GO:0019814
GeneOntologyCellularComponent	IgM immunoglobulin complex, circulating	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	9.49e-07	8	229	4	GO:0071754
GeneOntologyCellularComponent	pentameric IgM immunoglobulin complex	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	9.49e-07	8	229	4	GO:0071756
GeneOntologyCellularComponent	monomeric IgA immunoglobulin complex	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	1.69e-06	9	229	4	GO:0071748
GeneOntologyCellularComponent	polymeric IgA immunoglobulin complex	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	2.80e-06	10	229	4	GO:0071749
GeneOntologyCellularComponent	IgA immunoglobulin complex, circulating	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	2.80e-06	10	229	4	GO:0071746
GeneOntologyCellularComponent	secretory IgA immunoglobulin complex	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	2.80e-06	10	229	4	GO:0071751
GeneOntologyCellularComponent	blood microparticle	IGKV1-5 IGKV2D-28 IGKV1D-33 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-30 IGKV1-39 IGKV1-17	4.36e-06	144	229	10	GO:0072562
GeneOntologyCellularComponent	IgA immunoglobulin complex	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	1.74e-05	15	229	4	GO:0071745
GeneOntologyCellularComponent	IgM immunoglobulin complex	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	1.74e-05	15	229	4	GO:0071753
GeneOntologyCellularComponent	immunoglobulin complex, circulating	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	2.99e-05	17	229	4	GO:0042571
GeneOntologyCellularComponent	euchromatin	SETD1A SP1 TRIM24 TCF3 SETD5	1.16e-03	72	229	5	GO:0000791
Domain	PH_dom-like	TRIO IQSEC2 PLEKHH1 ARHGAP22 PHLDB1 PTPN13 OSBP2 ACAP3 TNS3 RANBP3 DOK7 ASAP3 SH2B1 MTMR4 ARHGEF10 CADPS	8.33e-06	426	191	16	IPR011993
Domain	-	TRIO IQSEC2 PLEKHH1 ARHGAP22 PHLDB1 PTPN13 OSBP2 ACAP3 TNS3 RANBP3 DOK7 ASAP3 SH2B1 MTMR4 CADPS	1.25e-05	391	191	15	2.30.29.30
Domain	N-SET	SETD1A SETD1B	1.04e-04	2	191	2	PF11764
Domain	N-SET	SETD1A SETD1B	1.04e-04	2	191	2	SM01291
Domain	COMPASS_Set1_N-SET	SETD1A SETD1B	1.04e-04	2	191	2	IPR024657
Domain	PH	TRIO IQSEC2 PLEKHH1 ARHGAP22 PHLDB1 OSBP2 ACAP3 DOK7 ASAP3 SH2B1 CADPS	1.41e-04	278	191	11	SM00233
Domain	PH_DOMAIN	TRIO IQSEC2 PLEKHH1 ARHGAP22 PHLDB1 OSBP2 ACAP3 DOK7 ASAP3 SH2B1 CADPS	1.46e-04	279	191	11	PS50003
Domain	PH_domain	TRIO IQSEC2 PLEKHH1 ARHGAP22 PHLDB1 OSBP2 ACAP3 DOK7 ASAP3 SH2B1 CADPS	1.51e-04	280	191	11	IPR001849
Domain	CCDC85	CCDC85B CCDC85C	3.10e-04	3	191	2	IPR019359
Domain	CCDC85	CCDC85B CCDC85C	3.10e-04	3	191	2	PF10226
Domain	RGM_N	RGMB HJV	3.10e-04	3	191	2	IPR010536
Domain	RGM_C	RGMB HJV	3.10e-04	3	191	2	PF06534
Domain	RGM_N	RGMB HJV	3.10e-04	3	191	2	PF06535
Domain	RGM_C	RGMB HJV	3.10e-04	3	191	2	IPR009496
Domain	PH	TRIO PLEKHH1 ARHGAP22 PHLDB1 OSBP2 ACAP3 ASAP3 SH2B1 CADPS	5.99e-04	229	191	9	PF00169
Domain	CLASP_N	CLASP1 TOGARAM2	6.16e-04	4	191	2	PF12348
Domain	CLASP_N_dom	CLASP1 TOGARAM2	6.16e-04	4	191	2	IPR024395
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	5.72e-23	61	158	19	M27581
Pathway	REACTOME_FCGR_ACTIVATION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	8.26e-22	69	158	19	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	8.26e-22	69	158	19	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.52e-21	71	158	19	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.52e-21	71	158	19	M27203
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.87e-20	80	158	19	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	3.11e-20	82	158	19	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	8.31e-20	86	158	19	M601
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	8.31e-20	86	158	19	M27206
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.05e-19	87	158	19	M27205
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	6.29e-19	95	158	19	M29842
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.18e-18	98	158	19	M27152
Pathway	REACTOME_COMPLEMENT_CASCADE	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	2.80e-17	115	158	19	M19752
Pathway	REACTOME_PARASITE_INFECTION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	3.32e-17	116	158	19	M29843
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	5.41e-16	134	158	19	M29840
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	7.18e-16	136	158	19	M27207
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.87e-15	143	158	19	M27107
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	7.55e-15	154	158	19	M39007
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	3.06e-14	166	158	19	M608
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	CEACAM5 IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	4.67e-14	194	158	20	M16312
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	2.47e-13	186	158	19	M27175
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	3.64e-13	190	158	19	M8240
Pathway	REACTOME_LEISHMANIA_INFECTION	IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 DVL2	4.69e-13	219	158	20	M29836
Pathway	REACTOME_SARS_COV_INFECTIONS	SP1 IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 CREBBP PARP10 AGRN	2.68e-09	471	158	23	M39009
Pathway	REACTOME_HEMOSTASIS	CEACAM5 KIF26A GATA6 DGKQ IGKV1-5 ADRA2C STXBP2 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 CARMIL1 SH2B1	8.31e-09	679	158	27	M8395
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	KIF26A DENND2B IGKV1-5 DENND4B SEC16A DENND6B IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 DVL2 NAA30	1.29e-07	725	158	26	M27507
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	TPP2 KIF26A IGKV1-5 HECW2 FBXW5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 HERC1 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.66e-05	828	158	24	M1058
Pathway	REACTOME_VIRAL_INFECTION_PATHWAYS	SP1 DAXX IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 CREBBP PARP10 NCOR2 AGRN	1.77e-05	888	158	25	M48034
Pathway	REACTOME_INFECTIOUS_DISEASE	SP1 DAXX IGKV1-5 IGKV3D-20 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 DVL2 CREBBP PARP10 NCOR2 AGRN	1.66e-04	1081	158	26	M27548
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	SETD1A SETD1B MEN1 KANSL1	8.33e-04	38	158	4	MM17073
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	SETD1A SETD1B MEN1 KANSL1	1.22e-03	42	158	4	M48018
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	SP1 SREBF1 SREBF2 CREBBP	1.22e-03	42	158	4	M27172
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP LRRFIP1	1.22e-03	5	158	2	M27228
Pubmed	Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome.	IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV2-28 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-9 IGKV1-8 IGKV1-6	8.54e-35	20	236	17	10427970
Pubmed	Human myeloperoxidase in innate and acquired immunity.	IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8	1.52e-30	18	236	15	20399194
Pubmed	Evolutionary dynamics of the human immunoglobulin kappa locus and the germline repertoire of the Vkappa genes.	IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8	3.92e-30	36	236	18	11298326
Pubmed	Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.	IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-9 IGKV1-8	1.11e-24	11	236	11	6795447
Pubmed	Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.	IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-9 IGKV1-8	1.11e-24	11	236	11	279004
Pubmed	Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes.	IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-9 IGKV1-8	1.11e-24	11	236	11	6767723
Pubmed	Variation in the crossover point of kappa immunoglobulin gene V-J recombination: evidence from a cryptic gene.	IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-6	3.57e-17	9	236	8	6777049
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-6	1.71e-16	77	236	14	15608191
Pubmed	Structure and implied functions of truncated B-cell receptor mRNAs in early embryo and adult mesenchymal stem cells: Cdelta replaces Cmu in mu heavy chain-deficient mice.	IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-6	4.90e-14	16	236	8	17124007
Pubmed	The human immunoglobulin kappa locus. Characterization of the duplicated A regions.	IGKV2D-30 IGKV2D-24 IGKV1D-17 IGKV2-30 IGKV2-29 IGKV2-28 IGKV1-27	7.15e-14	10	236	7	1551402
Pubmed	The V kappa genes of the L regions and the repertoire of V kappa gene sequences in the human germ line.	IGKV3D-15 IGKV1D-43 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-11 IGKV1-17 IGKV1-12	9.20e-14	17	236	8	8223863
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A SETD1B TRIO KIF26A SPEG SREBF1 PEX6 DGKQ FYCO1 SFI1 PRAG1 CIC PHLDB1 ZNRF3 GLI1 MAD1L1 SEC16A MLLT6 HERC1 SZT2 HECTD4 ARHGAP17 HES2 CCDC142 NCOR2 SEPHS2 KANSL1 SETD5 CDK13 LTBP3 AGRN CEP170B HTT	1.08e-12	1105	236	33	35748872
Pubmed	The human immunoglobulin kappa locus. Characterization of the duplicated O regions.	IGKV2D-40 IGKV1D-39 IGKV2-40 IGKV1-39 IGKV1-37	1.38e-11	5	236	5	1907917
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TRIO IQSEC2 PRAG1 DENND2B CIC ITPKB PHLDB1 PTPN13 STARD9 MAD1L1 SEC16A KIF5C TNS3 RBM15 CLASP1 RANBP3 CARMIL1 CCDC85C ARHGAP17 SIK3 ARAF MTMR4 FAM171A2 ARHGEF10 OTUD7A CEP170B SAMD4A	4.91e-11	861	236	27	36931259
Pubmed	The human VK locus. Characterization of a duplicated region encoding 28 different immunoglobulin genes.	IGKV3D-20 IGKV2D-28 IGKV2D-26 IGKV3-20 IGKV2-24	8.23e-11	6	236	5	3351922
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RABEP2 TPP2 TRIO IQSEC2 FYCO1 ARMCX4 LMTK3 MAD1L1 SEC16A KIF5C TACC3 SHANK1 TRIM46 CLASP1 HECTD4 DVL2 SPECC1L ARHGAP39 SIK3 NCOR2 FAM171A2 WTIP DCHS1 GOLGA8B BRSK1 AGRN CEP170B LRRFIP1	1.19e-10	963	236	28	28671696
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	RABEP2 SPEG PHLDB1 HERC1 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV4-1 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 RBM15 CLASP1 CARMIL1 PCDHB9 TOGARAM2 ARAF RNFT2	1.72e-09	497	236	19	36774506
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SNPH SETD1B TRO SPEG PLEKHH1 PHLDB1 KIDINS220 STARD9 RHOBTB2 DENND4B SEC16A CLASP1 KANSL1 SETD5 CADPS ASXL2 CEP170B	3.43e-09	407	236	17	12693553
Pubmed	Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.	IGKV1-5 IGKV2D-28 IGKV1D-33 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-40 IGKV2-30 IGKV1-39 IGKV1-17	4.38e-09	143	236	11	22516433
Pubmed	Organization and evolution of a gene cluster for human immunoglobulin variable regions of the kappa type.	IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8	1.03e-08	5	236	4	6086934
Pubmed	Mouse immunoglobulin chains. Pattern of sequence variation among kappa chains with limited sequence differences.	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	3.07e-08	6	236	4	4691517
Pubmed	Primary structures of N-terminal extra peptide segments linked to the variable and constant regions of immunoglobulin light chain precursors: implications on the organization and controlled expression of immunoglobulin genes.	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	3.07e-08	6	236	4	98179
Pubmed	Mechanisms of antibody diversity: multiple genes encode structurally related mouse kappa variable regions.	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	3.07e-08	6	236	4	99744
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGKV1-5 IGKV3D-20 IGKV1D-33 IGKV4-1 IGKV3-20 IGKV2-40 IGKV2-24	3.52e-08	48	236	7	11955599
Pubmed	The 3' part of the immunoglobulin kappa locus of the mouse.	IGKV3D-20 IGKV3D-15 IGKV3-20 IGKV3-15	7.12e-08	7	236	4	9603450
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRIO SREBF2 DENND2B ITPKB PLEKHH1 BPTF PHLDB1 PTPN13 KIDINS220 FBXO42 MAD1L1 KIF5C FAM149A TCF3 CARMIL1 HECTD4 CCDC85C ARHGAP39 CREBBP SH2B1 PARP10 NCOR2 SETD5 CDK13 ASPH ZFHX3 LZTS2 CSMD1 CEP170B HTT	1.13e-07	1489	236	30	28611215
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PEX6 TRIM24 ANKRD54 BPTF ZNRF3 PRPF40B SUN2 SEC16A ABHD8 INO80E ATN1 DVL2 ZBTB9 SIK3 CREBBP ARAF NCOR2 SOWAHA SETD5 CADPS IL21R ZFHX3 LZTS2 CSMD1 CEP170B	2.01e-07	1116	236	25	31753913
Pubmed	Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import.	SREBF1 SREBF2 HTT	3.09e-07	3	236	3	31875875
Pubmed	Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous.	IGKV1D-33 IGKV1-33 IGKV1-6	3.09e-07	3	236	3	1940382
Pubmed	Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.	IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28	8.13e-07	75	236	7	31527668
Pubmed	SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.	SREBF1 SREBF2 CREBBP	1.23e-06	4	236	3	8918891
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SP1 DAXX CIC FBXO38 BPTF MAD1L1 SEC16A TACC3 RBM15 ATN1 CLASP1 CARMIL1 SNX33 ARHGAP39 NCOR2 KANSL1 CDK13 ASPH LRRFIP1	1.68e-06	774	236	19	15302935
Pubmed	A Cascade of Wnt, Eda, and Shh Signaling Is Essential for Touch Dome Merkel Cell Development.	GLI1 KRT17 EDA EN1	2.66e-06	15	236	4	27414798
Pubmed	A census of human transcription factors: function, expression and evolution.	SP1 SREBF1 SREBF2 GATA6 NR4A1 CIC HOXD1 GLI1 ZNF541 PRRX2 FOXL1 SOX6 TCF3 LHX4 FOXN4 HES2 ZBTB7B ASCL2 ZFHX3 EN1	4.55e-06	908	236	20	19274049
Pubmed	Intracellular biosynthesis of lipids and cholesterol by Scap and Insig in mesenchymal cells regulates long bone growth and chondrocyte homeostasis.	SREBF2 GLI1 ACAN SOX6	5.87e-06	18	236	4	29899135
Pubmed	A human MAP kinase interactome.	SP1 KIF26A SREBF2 DAXX CIC SHANK1 KRT15 KRT17 ARHGAP17 SPECC1L SIK3 CREBBP ARAF KANSL1	6.90e-06	486	236	14	20936779
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SP1 ZNF185 SREBF1 SREBF2 GATA6 NR4A1 CIC GLI1 ZNF358 TACC3 FOXL1 TCF3 FOXN4 ZBTB7B CREBBP RNF146 ZFHX3	8.16e-06	709	236	17	22988430
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NR4A1 TRIM24 CREBBP NCOR2	9.19e-06	20	236	4	11877444
Pubmed	Myosin-reactive autoantibodies in rheumatic carditis and normal fetus.	IGKV3D-15 IGKV1D-8 IGKV3-20	1.06e-05	7	236	3	9614934
Pubmed	Activation of C1r by proteolytic cleavage.	IGKV1-5 IGKV3D-20 IGKV1D-33 IGKV4-1 IGKV2-24	1.08e-05	43	236	5	1249422
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO PTPN13 KIDINS220 FBXO42 SEC16A TNS3 CLASP1 LZTS2 CEP170B	1.42e-05	209	236	9	36779422
Pubmed	Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.	SP1 ATN1 HTT	2.51e-05	9	236	3	9535906
Pubmed	Interaction network of human early embryonic transcription factors.	SETD1A TRIM24 BPTF SEC16A INO80E ATN1 ZBTB9 CREBBP NCOR2 ZFHX3 ASXL2	3.15e-05	351	236	11	38297188
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	SP1 XIRP1 KIF26A LMTK3 PLEKHH1 STARD9 DNAJB2 TNS3 PARP10	3.35e-05	233	236	9	37704626
Pubmed	Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.	TRIM24 CREBBP NCOR2	3.57e-05	10	236	3	30595551
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SETD1A SP1 TRO LMTK3 CIC MLLT6 ATN1 RANBP3 ASAP3 SH2B1 NCOR2 LRRFIP1	4.27e-05	430	236	12	35044719
Pubmed	Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.	IGKV2D-28 IGKV2-28	4.59e-05	2	236	2	12833571
Pubmed	Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1') account for the major subfamilies of the mouse V kappa-1 variability subgroup.	IGKV2D-28 IGKV2-28	4.59e-05	2	236	2	3100621
Pubmed	Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.	CEACAM5 MUC16	4.59e-05	2	236	2	24680660
Pubmed	Sterol regulatory element-binding proteins are regulators of the sodium/iodide symporter in mammary epithelial cells.	SREBF1 SREBF2	4.59e-05	2	236	2	27614840
Pubmed	Daxx inhibits muscle differentiation by repressing E2A-mediated transcription.	DAXX TCF3	4.59e-05	2	236	2	19308989
Pubmed	Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.	SREBF1 SREBF2	4.59e-05	2	236	2	15062879
Pubmed	Menin directly represses Gli1 expression independent of canonical Hedgehog signaling.	MEN1 GLI1	4.59e-05	2	236	2	23928057
Pubmed	Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study.	SREBF1 SREBF2	4.59e-05	2	236	2	28367087
Pubmed	Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model.	SREBF1 SREBF2	4.59e-05	2	236	2	16879892
Pubmed	Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro.	SREBF1 CREBBP	4.59e-05	2	236	2	9765204
Pubmed	Structural and affinity studies of IgM polyreactive natural autoantibodies.	IGKV2D-28 IGKV2-28	4.59e-05	2	236	2	8993018
Pubmed	SREBP transcription factors: master regulators of lipid homeostasis.	SREBF1 SREBF2	4.59e-05	2	236	2	15589694
Pubmed	Transcriptional regulation of phagocytosis-induced membrane biogenesis by sterol regulatory element binding proteins.	SREBF1 SREBF2	4.59e-05	2	236	2	16141315
Pubmed	Identification of the downstream molecules of agrin/Dok-7 signaling in muscle.	DOK7 AGRN	4.59e-05	2	236	2	32043676
Pubmed	Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77.	NR4A1 NCOR2	4.59e-05	2	236	2	11559707
Pubmed	Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.	CREBBP HTT	4.59e-05	2	236	2	16456924
Pubmed	Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.	SREBF1 SREBF2	4.59e-05	2	236	2	10585467
Pubmed	Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.	CEACAM5 MUC16	4.59e-05	2	236	2	34801967
Pubmed	Phage display of a human antibody against Clostridium tetani toxin.	IGKV1D-39 IGKV1-39	4.59e-05	2	236	2	7926831
Pubmed	Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects.	KRT17 TMEM79	4.59e-05	2	236	2	24084074
Pubmed	Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1.	SP1 SREBF1	4.59e-05	2	236	2	20971080
Pubmed	Contribution of human V kappa II germ-line genes to light-chain diversity.	IGKV1-5 IGKV2D-28	4.59e-05	2	236	2	6325927
Pubmed	V genes of oxazolone antibodies in 10 strains of mice.	IGKV2D-28 IGKV2-28	4.59e-05	2	236	2	1936125
Pubmed	The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo.	BMP6 HJV	4.59e-05	2	236	2	20363739
Pubmed	Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.	CREBBP HTT	4.59e-05	2	236	2	15994095
Pubmed	Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.	CREBBP HTT	4.59e-05	2	236	2	16766198
Pubmed	SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.	DAXX CREBBP	4.59e-05	2	236	2	16287980
Pubmed	Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16.	IGKV2D-28 IGKV2-28	4.59e-05	2	236	2	2110659
Pubmed	Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.	SREBF1 SREBF2	4.59e-05	2	236	2	18936756
Pubmed	Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.	SREBF1 SREBF2	4.59e-05	2	236	2	29449559
Pubmed	SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene.	SREBF1 SREBF2	4.59e-05	2	236	2	8402897
Pubmed	SREBF1c and SREBF2 gene polymorphisms are associated with acute coronary syndrome and blood lipid levels in Mexican population.	SREBF1 SREBF2	4.59e-05	2	236	2	31490983
Pubmed	Sp1 regulates human huntingtin gene expression.	SP1 HTT	4.59e-05	2	236	2	22399227
Pubmed	CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.	SP1 SREBF1	4.59e-05	2	236	2	30258014
Pubmed	Expanding roles for SREBP in metabolism.	SREBF1 SREBF2	4.59e-05	2	236	2	23000402
Pubmed	Early alteration of epigenetic-related transcription in Huntington's disease mouse models.	CREBBP HTT	4.59e-05	2	236	2	29967375
Pubmed	Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity.	SP1 IL21R	4.59e-05	2	236	2	16260592
Pubmed	SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element.	SREBF1 SREBF2	4.59e-05	2	236	2	7903453
Pubmed	Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2.	SREBF1 SREBF2	4.59e-05	2	236	2	17921436
Pubmed	Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.	SREBF1 SREBF2	4.59e-05	2	236	2	9329978
Pubmed	Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2).	SREBF1 SREBF2	4.59e-05	2	236	2	9070916
Pubmed	WTIP interacts with ASXL2 and blocks ASXL2-mediated activation of retinoic acid signaling.	WTIP ASXL2	4.59e-05	2	236	2	25065743
Pubmed	The transcription factor Sp1 plays a crucial role in dok-7 gene expression.	SP1 DOK7	4.59e-05	2	236	2	21504746
Pubmed	Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway.	SREBF1 SREBF2	4.59e-05	2	236	2	16046411
Pubmed	A simple promoter containing two Sp1 sites controls the expression of sterol-regulatory-element-binding protein 1a (SREBP-1a).	SP1 SREBF1	4.59e-05	2	236	2	15462672
Pubmed	Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane.	SREBF1 SREBF2	4.59e-05	2	236	2	8626610
Pubmed	Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.	SREBF1 SREBF2	4.59e-05	2	236	2	16316337
Pubmed	Effects of a catechin-free fraction derived from green tea on gene expression of enzymes related to lipid metabolism in the mouse liver.	SREBF1 SREBF2	4.59e-05	2	236	2	22361881
Pubmed	CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription.	SREBF1 CREBBP	4.59e-05	2	236	2	9651391
Pubmed	Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA.	ATN1 HTT	4.59e-05	2	236	2	11442350
Pubmed	Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes.	SREBF1 SREBF2	4.59e-05	2	236	2	12177166
Pubmed	Association of sterol regulatory element-binding transcription factor gene polymorphisms with ischaemic stroke.	SREBF1 SREBF2	4.59e-05	2	236	2	22429355
Pubmed	Human immunoglobulin kappa light chain genes of subgroups II and III.	IGKV3-20 IGKV2-30	4.59e-05	2	236	2	2997711
Pubmed	SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.	SREBF1 SREBF2	4.59e-05	2	236	2	18072016
Interaction	YWHAH interactions	TRIO SPEG IQSEC2 PRAG1 DENND2B CIC PHLDB1 PTPN13 STARD9 MAD1L1 SEC16A KIF5C HERC1 TNS3 TICRR RBM15 CLASP1 RANBP3 CARMIL1 HECTD4 CCDC85C ARHGAP17 SNX33 SPECC1L SIK3 CREBBP ARAF MTMR4 FAM171A2 OTUD7A CEP170B HTT SAMD4A	1.46e-07	1102	221	33	int:YWHAH
Interaction	YWHAG interactions	SPEG IQSEC2 PRAG1 DENND2B CIC ITPKB PHLDB1 PTPN13 STARD9 MAD1L1 SEC16A KIF5C LTB4R TNS3 IGKV1-12 TICRR RBM15 CLASP1 RANBP3 CARMIL1 HECTD4 DVL2 CCDC85C ARHGAP17 SNX33 SPECC1L SIK3 ARAF MTMR4 FAM171A2 OTUD7A LZTS2 CEP170B HTT SAMD4A	2.82e-07	1248	221	35	int:YWHAG
Interaction	KDM6A interactions	SETD1A SETD1B MEN1 ARHGAP22 FOXL1 LHX4 CREBBP KANSL1 ASXL2 EN1 HTT	1.80e-06	162	221	11	int:KDM6A
Interaction	FBXO22 interactions	RABEP2 SPEG PHLDB1 HERC1 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV4-1 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 RBM15 CLASP1 CARMIL1 PCDHB9 TOGARAM2 ARAF NCOR2 RNFT2	2.28e-06	540	221	20	int:FBXO22
Interaction	KLF13 interactions	CHCHD10 SREBF1 SREBF2 ZBTB7B CREBBP	2.67e-06	21	221	5	int:KLF13
Interaction	TOP3B interactions	SETD1A SETD1B TRIO KIF26A SPEG SREBF1 PEX6 DGKQ FYCO1 SFI1 PRAG1 CIC PHLDB1 ZNRF3 GLI1 MAD1L1 SEC16A MLLT6 HERC1 FOXL1 RBM15 SZT2 HECTD4 DVL2 ARHGAP17 HES2 CCDC142 NCOR2 SEPHS2 KANSL1 SETD5 CDK13 LTBP3 AGRN CEP170B HTT	4.45e-06	1470	221	36	int:TOP3B
Interaction	NCOR2 interactions	SP1 NR4A1 FBXO38 FBXO42 SEC16A FOXL1 SOX6 LHX4 ZBTB7B CREBBP NCOR2 EN1 AGRN	7.47e-06	264	221	13	int:NCOR2
Interaction	HNF4A interactions	SETD1A SP1 SREBF1 SREBF2 TRIM24 CIC BPTF MUC19 ZBTB9 CREBBP NCOR2 KANSL1 ASXL2	1.16e-05	275	221	13	int:HNF4A
Interaction	KANSL2 interactions	SETD1A SETD1B MEN1 INO80E ATN1 DVL2 KANSL1	1.16e-05	70	221	7	int:KANSL2
Interaction	YY1 interactions	SETD1A SP1 SREBF1 TRIM24 CIC MEN1 BPTF FOXL1 INO80E TCF3 LHX4 ZBTB9 ZBTB7B CREBBP KANSL1 ASXL2 SF3A2	1.17e-05	454	221	17	int:YY1
Interaction	MYB interactions	SETD1A CIC MEN1 FBXW5 MLLT6 ZBTB9 CREBBP KANSL1 ZFHX3	1.64e-05	133	221	9	int:MYB
Interaction	KMT2C interactions	SETD1A SETD1B MEN1 FOXL1 LHX4 ATN1 ASCL2 ASXL2 EN1	1.74e-05	134	221	9	int:KMT2C
Interaction	PHF20 interactions	SETD1A SETD1B MEN1 ATN1 KANSL1 HTT	2.43e-05	53	221	6	int:PHF20
Interaction	TRPS1 interactions	CIC MEN1 SEC16A FOXL1 SOX6 LHX4 ZBTB7B ZFHX3 EN1	2.91e-05	143	221	9	int:TRPS1
Interaction	FOXK2 interactions	RABEP2 SETD1B CIC MEN1 BPTF HECW2 DVL2 NCOR2 MTMR4 KANSL1 ASXL2	4.05e-05	225	221	11	int:FOXK2
Interaction	HNF1B interactions	TRIM24 CIC BPTF MLLT6 SOX6 LHX4 CREBBP NCOR2 ZFHX3 ASXL2	4.90e-05	190	221	10	int:HNF1B
Interaction	ZNF608 interactions	SETD1A SETD1B MEN1 FOXL1 ATN1 KANSL1 EN1	7.39e-05	93	221	7	int:ZNF608
Interaction	KANSL1 interactions	SETD1A SETD1B MEN1 CCDC85B KRT15 ATN1 KANSL1	9.04e-05	96	221	7	int:KANSL1
Interaction	SETD1A interactions	SETD1A SETD1B DAXX MEN1 INO80E ATN1 EDA CREBBP KANSL1	1.12e-04	170	221	9	int:SETD1A
Cytoband	2p12	IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	2.76e-58	117	236	38	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p11	IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	3.72e-47	213	236	38	chr2p11
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1-5 IGKV6D-41 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	2.87e-55	83	177	38	351
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8	6.39e-13	132	227	15	MM996
Coexpression	SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	IGKV1-5 IGKV2D-28 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-12	3.57e-11	16	227	7	M41742
Coexpression	HAY_BONE_MARROW_PLASMA_CELL	LMTK3 IGKV1-5 IGKV3D-15 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-12 BRSK1	2.42e-07	132	227	10	M39205
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	SETD1A CIC ANKRD54 ZNF358 DENND4B LTB4R TCF3 ATN1 SZT2 RANBP3 ARHGAP17 ZBTB7B SETD5 AGRN	1.67e-06	338	227	14	M17094
Coexpression	HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP	IGKV2D-30 IGKV1D-12 IGKV2-30 IGKV1-9	3.68e-06	13	227	4	M41033
Coexpression	GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	SFI1 ITPKB SUN2 TCF3 DVL2 SPECC1L SH2B1 MTMR4 CDK13	3.59e-05	185	227	9	M5643
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-9 IGKV1-6	6.54e-12	183	217	17	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-6	6.54e-12	183	217	17	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9	1.20e-11	163	217	16	Arv_SC-hpx_blastocyst_500_K2
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	CEACAM5 IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-17	1.36e-11	139	217	15	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9	3.54e-11	175	217	16	Arv_SC-H9hpx_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-17	4.48e-11	126	217	14	Arv_SC-HD_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9	6.13e-10	244	217	17	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2	CEACAM5 IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-9	1.08e-07	266	217	15	Arv_SC-hpx_blastocyst_1000_K2
CoexpressionAtlas	PP_HSC_top-relative-expression-ranked_2500_k-means-cluster#3	IGKV2D-40 IGKV2D-30 IGKV1D-39 IGKV4-1 IGKV2-40 IGKV2-30 PRRX2 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 TOGARAM2 ASCL2 INPP5J	4.52e-07	339	217	16	PP_HSC_2500_K3
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9	7.98e-07	492	217	19	Arv_SC-H9hpx_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9	7.98e-07	492	217	19	Arv_SC-hpx_blastocyst_500
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-17	1.23e-05	489	217	17	Arv_SC-HD_500
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-17	1.23e-05	489	217	17	Arv_SC_fibroblast_500
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3	XIRP1 GATA6 GCGR IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 SOX6 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 PCDHB10 INPP5J	2.08e-05	848	217	23	ratio_ECTO_vs_SC_2500_K3
CoexpressionAtlas	geo_heart_top-relative-expression-ranked_2500_k-means-cluster#5	GATA6 FYCO1 IGKV1-5 IGKV3D-20 PROB1 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-24 HJV IGKV1-17 IGKV1-12 DOK7 TOGARAM2 MUC16 PDE8B SRRM3 INPP5J	3.53e-05	586	217	18	geo_heart_2500_K5
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 KIF5C IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 LHX4 TOGARAM2	7.63e-05	986	217	24	Arv_SC_fibroblast_1000
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 KIF5C IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 LHX4 TOGARAM2	7.63e-05	986	217	24	Arv_SC-HD_1000
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 KIF5C IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 LHX4 MUC19	7.75e-05	987	217	24	Arv_SC-H9hpx_1000
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	CEACAM5 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 KIF5C IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 LHX4 MUC19	7.75e-05	987	217	24	Arv_SC-hpx_blastocyst_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	CHCHD10 UNC5B LMTK3 ANKRD54 MLLT6 INO80E RBM45 DVL2 CCDC85C MINPP1 ARAF MTMR4 KANSL1	8.84e-05	359	217	13	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K3
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	CHCHD10 ZNF185 GATA6 NR4A1 DENND2B ITPKB PTPN13 STXBP2 ZNRF3 STARD9 HECW2 TNS3 SOX6 SZT2 CARMIL1 ARHGAP39 MINPP1 NCOR2 CADPS SF3A2 CEP170B	3.02e-04	884	217	21	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_100	RGMB HOXD1 KIF5C KRT15 CADPS AGRN	3.05e-04	89	217	6	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_100
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000	TRIO PTPRU MSRB3 KANSL1 ASXL2 AGRN	3.44e-04	91	217	6	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	RGMB TRIO ZC3H6 HOXD1 KIF5C KRT15 MSRB3 AGRN	3.72e-04	170	217	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-28 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 WDR87 OTUD7A	4.99e-35	195	236	30	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 FCRL1 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	2.65e-33	197	236	29	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-5 BMP6 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8	3.00e-33	175	236	28	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 TICRR IGKV1-9 IGKV1-8 IGKV1-6	6.24e-32	194	236	28	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-5 BMP6 IGKV3D-20 IGKV3D-15 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	1.24e-30	190	236	27	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-5 BMP6 IGKV3D-20 IGKV3D-15 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	1.24e-30	190	236	27	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-29 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	2.98e-30	196	236	27	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6	5.45e-30	176	236	26	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6	6.64e-29	193	236	26	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	3.09e-28	179	236	25	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-40 IGKV2-30 IGKV2-24 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	3.09e-28	179	236	25	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	3.09e-28	179	236	25	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FCRL1 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-26 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-6	3.69e-27	197	236	25	2662138671262b30508c5759038bcdcfe6551696
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-8	2.38e-26	185	236	24	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-8	2.38e-26	185	236	24	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 FAM149A IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6 TCF3	2.72e-26	186	236	24	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	6.78e-26	193	236	24	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	9.92e-26	196	236	24	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	9.92e-26	196	236	24	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-24 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	2.59e-25	177	236	23	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-24 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	2.59e-25	177	236	23	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-40 IGKV2D-30 IGKV2D-24 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	2.59e-25	177	236	23	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	5.72e-25	183	236	23	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV2D-24 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-12 IGKV1-8 IGKV1-6	2.56e-24	195	236	23	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	IGKV1-5 BMP6 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-13 IGKV1-12	4.20e-24	172	236	22	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-27 IGKV1-12 IGKV1-8 IGKV1-6	4.79e-24	173	236	22	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 FCRL1 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-8	9.12e-24	178	236	22	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	2.32e-23	159	236	21	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-15 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	3.48e-23	162	236	21	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-15 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	3.48e-23	162	236	21	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	4.46e-23	191	236	22	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	7.10e-23	195	236	22	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	2.08e-22	176	236	21	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	2.08e-22	176	236	21	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-12 IGKV1-8	4.81e-22	183	236	21	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	6.07e-22	185	236	21	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	6.07e-22	185	236	21	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	8.56e-22	188	236	21	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6	6.52e-21	177	236	20	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV2D-30 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-12 WDR87 BRSK1	9.17e-21	180	236	20	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV1D-43 IGKV1D-17 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	1.03e-20	181	236	20	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-40 IGKV2-28 IGKV2-24 IGKV1-37 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-6	4.17e-20	194	236	20	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV2-40 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	4.63e-20	195	236	20	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	LMTK3 IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-37 IGKV1-12 IGKV1-6	5.54e-20	167	236	19	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	LMTK3 IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-37 IGKV1-12 IGKV1-6	5.54e-20	167	236	19	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	10x5'-GI_large-bowel\|World / Manually curated celltypes from each tissue	CEACAM5 NR4A1 IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-11 IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	6.21e-20	168	236	19	1290c909655bc37f6b8bf216d18127a21b99e9c0
ToppCell	wk_08-11-Hematologic_Lymphocytic-B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FCRL1 IGKV3D-15 IGKV2D-30 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-13 IGKV1-8	9.79e-20	172	236	19	d1ab8f493b70ec995281f9fb0991f1d3aa7b928f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	3.97e-19	185	236	19	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	3.97e-19	185	236	19	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	IPF-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	IGKV1-5 BMP6 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12	4.40e-19	186	236	19	f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-5 IGKV3D-20 IGKV2D-29 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-9 IGKV1-8 IGKV1-6 CARMIL1	5.97e-19	189	236	19	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-27 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 C20orf202	1.80e-18	169	236	18	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	3.76e-18	176	236	18	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	COPD-Lymphoid-B_Plasma\|COPD / Disease state, Lineage and Cell class	IGKV1-5 BMP6 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-17 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-30 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-8 CARMIL1	4.16e-18	177	236	18	1b872d3b1e0fca138362098590a634d748dfca60
ToppCell	normal_Lymph_Node-B_lymphocytes-Plasma_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	LMTK3 IGKV1-5 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-28 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 BRSK1	6.24e-18	181	236	18	949ac3b60e7fb5968da4c4e872965fb4e10f4a35
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-28 IGKV2-24 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9	1.24e-17	188	236	18	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	Biopsy_Control_(H.)-Immune-Plasma_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 IGKV1-39 IGKV1-12 IGKV1-8 BRSK1	2.86e-17	197	236	18	275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCell	IPF-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-37 IGKV1-13 IGKV1-12	8.69e-17	176	236	17	cc0cab6487df6867b529596ec94f55d31aa6ca36
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGKV3D-20 IGKV3D-15 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-24 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9	1.85e-16	184	236	17	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-17 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9	5.37e-16	196	236	17	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LMTK3 IGKV1-5 IGKV3D-20 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-8 BRSK1	5.37e-16	196	236	17	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Control-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-5 BMP6 IGKV3D-20 IGKV2D-30 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-13 IGKV1-12	1.08e-15	170	236	16	fb05f49b7113470995b3c16683c54dc1a660b73a
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-5 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6	1.08e-15	170	236	16	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGKV1-5 IGKV3D-20 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-37 IGKV1-27 IGKV1-12 IGKV1-9 BRSK1	1.52e-15	142	236	15	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	VE-plasma\|VE / Condition, Cell_class and T cell subcluster	BMP6 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-6	2.05e-15	177	236	16	0c1cc0834de55717cb4f69d020339060ce2c9a03
ToppCell	VE-plasma-\|VE / Condition, Cell_class and T cell subcluster	BMP6 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-6	2.05e-15	177	236	16	3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d
ToppCell	TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-2\|TCGA-Stomach / Sample_Type by Project: Shred V9	IGKV6D-41 IGKV3D-15 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-28 IGKV1-37 IGKV1-33	5.29e-15	124	236	14	9d62f997a1a389386e8d83652bdf109c2a1c96d8
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-12 TICRR IGKV1-9 IGKV1-8 IGKV1-6	6.26e-15	156	236	15	4f92ca30755430db44402afc603d1ecd8bfc3617
ToppCell	390C-Lymphocytic-Plasma_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-12 TICRR IGKV1-9 IGKV1-8 IGKV1-6	6.26e-15	156	236	15	0de2fc695bd5f8d4633c514f71ea941c88137bac
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LMTK3 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 BRSK1	9.51e-15	195	236	16	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells\|Lung / Manually curated celltypes from each tissue	BMP6 IGKV3D-20 IGKV2D-29 IGKV2D-24 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV2-24 IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-8	1.32e-14	164	236	15	3b6a32ba53d05f6818fe950ac426f489383b645a
ToppCell	Plasma_cells\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-5 IGKV3D-15 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-28 IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	2.93e-14	173	236	15	52a387e2a4694af61a9223a4c2ecf4e6f762c064
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-5 FCRL1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	5.72e-14	181	236	15	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-5 FCRL1 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-29 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	6.73e-14	183	236	15	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-5 FCRL1 IGKV2D-28 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-29 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	6.73e-14	183	236	15	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	5'-Adult-LargeIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM5 IGKV1-5 IGKV3D-20 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6	1.71e-13	195	236	15	600174e35574fe7c44dd923adcf43686e7b01e39
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	1.74e-13	159	236	14	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 FCRL1 IGKV3D-15 IGKV1D-39 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-27 IGKV1-12 IGKV1-8	1.99e-13	197	236	15	88b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 FCRL1 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-33 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12	1.99e-13	197	236	15	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGKV1-5 IGKV3D-20 IGKV3D-15 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV3-11 IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8	1.99e-13	197	236	15	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 FCRL1 IGKV3D-20 IGKV2D-24 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 IGKV1-33 IGKV1-17	1.99e-13	197	236	15	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 FCRL1 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-33 IGKV4-1 IGKV3-20 IGKV2-29 IGKV2-28 IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-12	2.31e-13	199	236	15	8e02d3a066e79e0f2024a10738e0ea070513ef19
ToppCell	3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells\|blood / Manually curated celltypes from each tissue	IGKV1-5 IGKV2D-29 IGKV2D-26 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 IGKV1-17 IGKV1-12	2.90e-13	165	236	14	1c0c24fe252b761cf879b83562e23c02f0b6489f
ToppCell	390C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-12 TICRR IGKV1-9 IGKV1-8 IGKV1-6	3.15e-13	166	236	14	4ba3711a02d3695b27f7cefd7c60e3be009f5bef
ToppCell	390C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV1-39 IGKV1-12 TICRR IGKV1-9 IGKV1-8 IGKV1-6	3.15e-13	166	236	14	35f6ae2664935dda0d883b32a050ced843204f2d
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV2-30 IGKV2-29 IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6	4.04e-13	169	236	14	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV1D-43 IGKV1D-17 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	9.60e-13	180	236	14	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	LMTK3 IGKV3D-20 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-37 IGKV1-27 IGKV1-12 BRSK1	1.12e-12	182	236	14	27d1688fdfc570cedd233aa7030bce7d9b604d42
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	IGKV1-5 BMP6 IGKV2D-28 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV4-1 IGKV3-20 IGKV2-28 IGKV1-17 IGKV1-13 IGKV1-9 BRSK1	1.20e-12	183	236	14	a6866951866373a1029e04818f4a4a31278c409d
ToppCell	3'_v3-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	IGKV1-5 BMP6 IGKV2D-30 IGKV2D-29 IGKV1D-13 IGKV1D-8 IGKV4-1 IGKV3-11 IGKV2-40 IGKV2-30 IGKV2-28 IGKV1-17 IGKV1-12 IGKV1-6	1.20e-12	183	236	14	2477183a290b2c45b6fa091ed76969a3826fe3d9
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV2D-28 IGKV1D-16 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	1.30e-12	184	236	14	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV2D-28 IGKV1D-16 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 BRSK1	1.30e-12	184	236	14	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	IGKV3D-20 IGKV3D-15 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV3-11 IGKV2-24 IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-9	1.50e-12	186	236	14	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-5 FCRL1 IGKV3D-20 IGKV3D-15 IGKV2D-30 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV1-39 IGKV1-33 CARMIL1	1.74e-12	188	236	14	c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV2-30 IGKV1-27 IGKV1-12 IGKV1-9	2.16e-12	191	236	14	da4062a0f6d0af6d330acf11da216c64b0fa7c73
ToppCell	normal_Lymph_Node-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	LMTK3 IGKV1-5 IGKV2D-28 IGKV2D-24 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV2-30 IGKV2-28 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6	2.32e-12	192	236	14	119832d4aee29ddda2485fc3e5dcdaacf833cc30
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-5 BMP6 IGKV3D-20 IGKV3D-15 IGKV1D-17 IGKV1D-13 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-6	2.67e-12	194	236	14	f083777353e76a2d9c39f8b6cb1a689b68b81c56
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	IGKV1-5 IGKV3D-20 IGKV2D-30 IGKV1D-39 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 TCF3	3.77e-12	199	236	14	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV3D-20 IGKV2D-28 IGKV1D-16 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-27 IGKV1-12 IGKV1-8 IGKV1-6	9.79e-12	173	236	13	0ca2169a275404118038c0489a48062879488765
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV4-1 IGKV3-20 IGKV3-15 IGKV3-11 IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-8 IL21R	1.31e-11	177	236	13	ae2d2e138946535596fa30a55207f261cafda461
Drug	monastrol; Up 200; 100uM; MCF7; HG-U133A	RABEP2 TRIO UNC5B ITPKB FBXO38 MAD1L1 DVL2 SH2B1 RNFT2 ARHGEF10 AGRN SF3A2	2.29e-07	195	206	12	311_UP
Drug	Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	SREBF2 DENND2B PHLDB1 ZNF358 ATN1 ASAP3 HES2 NCOR2 ARHGEF10 PDE8B SLC20A2 DCAF11	2.71e-07	198	206	12	7380_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A	RABEP2 CCNO NR4A1 DENND2B PHLDB1 ACAN FBXO42 LTB4R EDA CREBBP SF3A2	1.83e-06	196	206	11	203_DN
Drug	Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A	BORCS6 RABEP2 SETD1A SFI1 LTB4R CCDC85C SH2B1 RNFT2 PDE8B ASPH CEP170B	1.92e-06	197	206	11	4160_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	CEACAM5 TRIO CCNO OSBP2 ABHD8 LTB4R TCF3 ATN1 EDA ZFHX3 AGRN	1.92e-06	197	206	11	4336_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TPP2 TRIO SREBF2 FBXO42 KIF5C TCF3 RANBP3 RNFT2 SLC20A2 RNF146 DCAF11	2.12e-06	199	206	11	3403_DN
Drug	Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A	RABEP2 IQSEC2 BMP6 MFAP3 PHLDB1 SUN2 ATN1 ASAP3 CCDC85C ASPH INPP5J	2.23e-06	200	206	11	6000_DN
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	SETD1A IQSEC2 CCNO MFAP3 ZNF358 TCF3 ASAP3 CCDC85C ZFHX3 DCAF11	1.05e-05	192	206	10	4462_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SETD1A UNC5B IQSEC2 SFI1 NR4A1 CIC KIDINS220 RANBP3 SF3A2 SAMD4A	1.10e-05	193	206	10	2209_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	IQSEC2 SFI1 ARHGAP22 PHLDB1 LTB4R SZT2 ASAP3 CDK13 AGRN INPP5J	1.10e-05	193	206	10	4322_UP
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	SP1 CEACAM5 TRIO KIF5C ATN1 CDK13 ZFHX3 DCAF11 AGRN SF3A2	1.15e-05	194	206	10	4246_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	RABEP2 CEACAM5 MFAP3 ZNF358 RHOBTB2 FBXO42 LTB4R PDE8B RNF146 ASPH	1.15e-05	194	206	10	3354_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	TRIO RHOBTB2 ATN1 CCDC85C PTPRU HES2 EDA ZFHX3 AGRN SF3A2	1.15e-05	194	206	10	4335_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A	BORCS6 IQSEC2 SFI1 LTB4R DNAJB2 DVL2 ASAP3 PTPRU CREBBP INPP5J	1.20e-05	195	206	10	2624_UP
Drug	prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	BORCS6 SFI1 LTB4R ATN1 RANBP3 DVL2 PTPRU SH2B1 NCOR2 PDE8B	1.20e-05	195	206	10	6552_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	CCNO SUN2 ABHD8 KIF5C ATN1 CCDC85C CDK13 ZFHX3 AGRN SAMD4A	1.25e-05	196	206	10	4292_DN
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A	RABEP2 CEACAM5 TRIO SFI1 RHOBTB2 LTB4R TCF3 CCDC85C PTPRU SH2B1	1.25e-05	196	206	10	2843_UP
Drug	Digoxigenin [1672-46-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	BORCS6 RABEP2 CEACAM5 SPEG ITPKB FBXO38 LTB4R ATN1 ASAP3 HES2	1.25e-05	196	206	10	3397_DN
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A	RABEP2 SETD1B SREBF2 PHLDB1 TCF3 HES2 CDK13 ASPH DCAF11 SAMD4A	1.25e-05	196	206	10	4724_UP
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A	CEACAM5 SETD1B SPEG SFI1 MFAP3 PHLDB1 ATN1 ARHGAP17 YRDC ASPH	1.31e-05	197	206	10	3255_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	BORCS6 SETD1A PHLDB1 LTB4R DNAJB2 ATN1 ARHGEF10 PDE8B SLC38A7 INPP5J	1.31e-05	197	206	10	5592_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	SETD1A SREBF1 SFI1 NR4A1 CIC SUN2 LTB4R PTPRU SH2B1 INPP5J	1.31e-05	197	206	10	2766_UP
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	IQSEC2 SFI1 HOXD1 TNS3 KRT15 RANBP3 CCDC85C SH2B1 NCOR2 CDK13	1.37e-05	198	206	10	3897_DN
Drug	raloxifene hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A	NR4A1 DENND2B PHLDB1 ACAN FBXO42 LTB4R ATN1 CREBBP NCOR2 ZFHX3	1.37e-05	198	206	10	202_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	BORCS6 SETD1A SFI1 CIC ATN1 DVL2 EDA SLC20A2 ASPH INPP5J	1.37e-05	198	206	10	5213_UP
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A	SETD1A NR4A1 ADRA2C TCF3 SZT2 ASAP3 SH2B1 ARHGEF10 INPP5J SAMD4A	1.43e-05	199	206	10	3345_DN
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TRIO UNC5B CCNO MFAP3 PHLDB1 KIDINS220 LTB4R DVL2 SH2B1 INPP5J	1.43e-05	199	206	10	3535_DN
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	RABEP2 SNPH BMP6 FBXO42 KIF5C HS1BP3 SIK3 RNF146 SF3A2 HTT	1.43e-05	199	206	10	1210_DN
Drug	nifedipine; Down 200; 10uM; MCF7; HG-U133A	TRIO NR4A1 AGBL5 CIC BMP6 ACAN DVL2 EDA SH2B1 DCHS1	1.43e-05	199	206	10	603_DN
Drug	2-chloroethylamine	CEACAM5 CCNO CHRM1	5.89e-05	9	206	3	CID000013369
Drug	Lanatoside C [17575-22-3]; Down 200; 4uM; PC3; HT_HG-U133A	SNPH CCNO ITPKB RHOBTB2 KIF5C TCF3 ATN1 RANBP3 LRRFIP1	6.36e-05	191	206	9	4328_DN
Drug	Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A	RABEP2 SPEG NR4A1 ACAN ATN1 ASAP3 EDA CREBBP NCOR2	6.62e-05	192	206	9	6050_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	BORCS6 TRIO SREBF2 SFI1 CIC ATN1 YRDC SPECC1L AGRN	6.89e-05	193	206	9	3262_UP
Drug	Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; MCF7; HT_HG-U133A	TRIO NR4A1 DENND2B TMEM11 BMP6 MFAP3 KIDINS220 DNAJB2 SZT2	6.89e-05	193	206	9	1703_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	CEACAM5 TRIO OSBP2 ATN1 EDA SH2B1 NCOR2 PDE8B ZFHX3	6.89e-05	193	206	9	4343_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A	IQSEC2 SREBF2 NR4A1 ARHGAP22 PHLDB1 KIDINS220 ACAN RHOBTB2 RNF146	6.89e-05	193	206	9	1817_UP
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; PC3; HT_HG-U133A	IQSEC2 CCNO DENND2B BMP6 ZNF358 NCOR2 CDK13 PDE8B ZFHX3	7.17e-05	194	206	9	6616_DN
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	CCNO FYCO1 DENND2B RANBP3 ASAP3 PDE8B AGRN SF3A2 HTT	7.17e-05	194	206	9	5630_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	SPEG NR4A1 DENND2B BMP6 MFAP3 RHOBTB2 KRT15 SZT2 SAMD4A	7.17e-05	194	206	9	4559_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	BORCS6 CEACAM5 SFI1 KIDINS220 RHOBTB2 KIF5C DVL2 EDA ARHGEF10	7.17e-05	194	206	9	4141_DN
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A	SREBF1 NR4A1 AGBL5 FBXO42 LTB4R TCF3 RANBP3 SLC38A7 CEP170B	7.46e-05	195	206	9	1410_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	SETD1B TRIO SPEG IQSEC2 FBXO38 KIF5C DVL2 HS1BP3 NCOR2	7.46e-05	195	206	9	3714_DN
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	SP1 GATA6 CCNO DNAJB2 TCF3 CCDC85C HS1BP3 PTPRU CEP170B	7.46e-05	195	206	9	3470_DN
Drug	Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A	CEACAM5 IQSEC2 PEX6 SFI1 NR4A1 BMP6 ADRA2C ATN1 SAMD4A	7.46e-05	195	206	9	4593_UP
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A	RABEP2 SETD1A KIF5C ATN1 ASAP3 EDA PDE8B ZFHX3 AGRN	7.46e-05	195	206	9	4326_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	SREBF2 SFI1 DENND2B ITPKB SUN2 DNAJB2 CLASP1 RANBP3 ARHGEF10	7.76e-05	196	206	9	3633_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	IQSEC2 CIC KIDINS220 LTB4R KRT15 RANBP3 PTPRU SLC38A7 AGRN	7.76e-05	196	206	9	2219_DN
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	SREBF2 PEX6 SFI1 BMP6 FBXO42 KIF5C CCDC85C HES2 AGRN	7.76e-05	196	206	9	6309_DN
Drug	Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CEACAM5 IQSEC2 SFI1 NR4A1 RHOBTB2 DVL2 EDA ARHGEF10 PDE8B	7.76e-05	196	206	9	4130_DN
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HG-U133A	SFI1 AGBL5 DENND2B PHLDB1 HOXD1 ACAN ZNF358 RANBP3 SLC38A7	7.76e-05	196	206	9	1952_UP
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SREBF2 SFI1 ITPKB FBXO38 KIDINS220 TCF3 KRT15 RANBP3 ASPH	7.76e-05	196	206	9	2239_DN
Drug	Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	CCNO ITPKB DNAJB2 TNS3 ARHGAP17 CDK13 SLC20A2 AGRN HTT	7.76e-05	196	206	9	1696_DN
Drug	CAY10397; Up 200; 10uM; PC3; HT_HG-U133A	RABEP2 KIF5C SZT2 DVL2 ASAP3 CDK13 SLC20A2 ASPH DCAF11	7.76e-05	196	206	9	7071_UP
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A	TRIO PEX6 SFI1 NR4A1 KIDINS220 ATN1 RANBP3 DVL2 EN1	8.07e-05	197	206	9	3143_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	CIC KIDINS220 ATN1 SZT2 NCOR2 ARHGEF10 CDK13 ZFHX3 SAMD4A	8.07e-05	197	206	9	4266_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	SETD1A ZNF358 ATN1 CCDC85C PTPRU CDK13 EN1 AGRN CEP170B	8.07e-05	197	206	9	4295_DN
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SFI1 DENND2B LTB4R KRT15 RANBP3 ASAP3 CREBBP SLC38A7 INPP5J	8.07e-05	197	206	9	2869_UP
Drug	Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A	RABEP2 SP1 SPEG IQSEC2 DGKQ SHANK1 RANBP3 ASAP3 ARHGEF10	8.07e-05	197	206	9	2773_UP
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; HL60; HG-U133A	UNC5B SFI1 NR4A1 ATN1 MTMR4 CDK13 ASPH AGRN SF3A2	8.07e-05	197	206	9	1774_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	RABEP2 SETD1A CCNO MFAP3 OSBP2 KRT15 RANBP3 PDE8B SAMD4A	8.07e-05	197	206	9	6222_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	RABEP2 STK17A CCNO PHLDB1 KIDINS220 KRT15 ATN1 EDA NCOR2	8.07e-05	197	206	9	5207_UP
Drug	Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	STK17A UNC5B DENND2B MFAP3 DNAJB2 KRT15 ATN1 CCDC85C INPP5J	8.39e-05	198	206	9	5413_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	SETD1A TRIO TRO SFI1 NYX NR4A1 ASCL2 EN1 SAMD4A	8.39e-05	198	206	9	3180_UP
Drug	Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A	RABEP2 UNC5B IQSEC2 NR4A1 ITPKB PHLDB1 MAD1L1 CCDC85C LRRFIP1	8.39e-05	198	206	9	5992_DN
Drug	Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; PC3; HT_HG-U133A	BORCS6 NR4A1 MFAP3 ACAN CCDC85C PTPRU EDA IL21R INPP5J	8.39e-05	198	206	9	5788_UP
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	RABEP2 CCNO NR4A1 RHOBTB2 ATN1 ASAP3 NCOR2 CDK13 SF3A2	8.39e-05	198	206	9	3901_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A	PLPPR3 MFAP3 FBXO42 LTB4R TCF3 SZT2 SH2B1 HTT SAMD4A	8.39e-05	198	206	9	2345_UP
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A	TRIO DGKQ SFI1 NR4A1 KIDINS220 HOXD1 ACAN RHOBTB2 OSBP2	8.39e-05	198	206	9	3703_UP
Drug	Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A	SREBF2 CCNO MFAP3 SZT2 CCDC85C PTPRU ZFHX3 DCAF11 SF3A2	8.72e-05	199	206	9	4799_DN
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A	STK17A IQSEC2 DENND2B LTB4R TCF3 CCDC85C PDE8B SLC20A2 INPP5J	8.72e-05	199	206	9	2625_UP
Drug	Ascorbic acid [50-81-7]; Down 200; 22.4uM; PC3; HT_HG-U133A	UNC5B SREBF2 SFI1 ZNF358 MAD1L1 ABHD8 KIF5C ASAP3 CCDC85C	8.72e-05	199	206	9	6306_DN
Drug	semustine; Down 200; 100uM; MCF7; HT_HG-U133A	SFI1 ITPKB MFAP3 PHLDB1 ZNF358 KRT15 ATN1 ASAP3 EDA	8.72e-05	199	206	9	7487_DN
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A	SETD1A SPEG SREBF2 SFI1 DENND2B KIF5C LTB4R RNFT2 SLC20A2	9.06e-05	200	206	9	3380_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SETD1B BPTF DENND4B TNS3 CREBBP CDK13 ZFHX3 SAMD4A	1.78e-04	172	206	8	1072_DN
Drug	AC1NDQB9	CHIT1 CCDC85B TCF3 ARAF	2.17e-04	33	206	4	CID004629888
Drug	Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	RABEP2 CCNO KIF5C RANBP3 ASAP3 HES2 NCOR2 DCAF11	3.25e-04	188	206	8	7124_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	TRO IQSEC2 NR4A1 ATN1 PTPRU NCOR2 ZFHX3 AGRN	3.37e-04	189	206	8	4304_UP
Drug	colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA	TRIO SREBF1 SUN2 DENND4B HECTD4 SPECC1L ARHGEF10 AGRN	3.49e-04	190	206	8	1103_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	CCNO DENND2B CIC ACAN ZNF358 TNS3 ARHGEF10 INPP5J	3.62e-04	191	206	8	3855_DN
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	BORCS6 SFI1 NR4A1 ITPKB MFAP3 PHLDB1 DVL2 SF3A2	3.74e-04	192	206	8	2271_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	UNC5B SREBF2 SFI1 HOXD1 NCOR2 SLC38A7 DCAF11 HTT	3.88e-04	193	206	8	6691_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; PC3; HT_HG-U133A	SP1 TRIO BMP6 OSBP2 KIF5C TCF3 ATN1 ZFHX3	3.88e-04	193	206	8	5050_DN
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A	ACAN LTB4R TRIM46 ATN1 RANBP3 PTPRU AGRN INPP5J	3.88e-04	193	206	8	4306_UP
Drug	6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; PC3; HT_HG-U133A	TRO PEX6 SFI1 ACAN RHOBTB2 PTPRU NCOR2 CDK13	3.88e-04	193	206	8	4477_UP
Drug	Methylatropine nitrate [52-88-0]; Down 200; 11uM; HL60; HT_HG-U133A	SETD1A IQSEC2 SFI1 HOXD1 RANBP3 SLC38A7 LTBP3 DCAF11	3.88e-04	193	206	8	3116_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	RABEP2 CCNO NR4A1 CIC PHLDB1 CCDC85C SH2B1 PDE8B	4.01e-04	194	206	8	4411_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	CIC MFAP3 SUN2 TCF3 PTPRU SLC20A2 DCAF11 LRRFIP1	4.01e-04	194	206	8	1060_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	BORCS6 ABHD8 TCF3 KRT15 ATN1 PTPRU RNF146 ZFHX3	4.01e-04	194	206	8	4341_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CIC LTB4R TCF3 RANBP3 RNFT2 CDK13 SLC20A2 SAMD4A	4.01e-04	194	206	8	1707_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A	RABEP2 CEACAM5 SREBF1 NR4A1 HOXD1 ACAN TCF3 RNF146	4.01e-04	194	206	8	1377_DN
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	RABEP2 SP1 UNC5B DGKQ NR4A1 BPTF MFAP3 SH2B1	4.01e-04	194	206	8	4391_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	ACAN ZNF358 TACC3 DNAJB2 TCF3 CCDC85C NCOR2 SF3A2	4.01e-04	194	206	8	433_DN
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A	BORCS6 CCNO ITPKB PHLDB1 RHOBTB2 LTB4R TCF3 DVL2	4.01e-04	194	206	8	5454_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	SETD1A IQSEC2 CCNO FBXO42 OSBP2 ATN1 RANBP3 ASPH	4.01e-04	194	206	8	6955_UP
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A	STK17A NR4A1 ARHGAP22 ZNF358 RHOBTB2 FAM149A DVL2 HES2	4.01e-04	194	206	8	2076_UP
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A	RABEP2 PEX6 NR4A1 KIDINS220 LTB4R CCDC85C ARHGEF10 CDK13	4.01e-04	194	206	8	2397_DN
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	SETD1A SFI1 PHLDB1 ABHD8 TCF3 HS1BP3 EDA DCAF11	4.01e-04	194	206	8	4642_UP
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A	SP1 PHLDB1 PTPN13 KIDINS220 MAD1L1 RANBP3 DVL2 PTPRU	4.15e-04	195	206	8	3512_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	BORCS6 SNPH GCGR ACAN ATN1 ARHGEF10 PDE8B IL21R	4.15e-04	195	206	8	6183_UP
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A	BORCS6 NR4A1 ZNF358 RHOBTB2 CCDC85B KRT15 ASAP3 NCOR2	4.15e-04	195	206	8	4734_UP
Disease	neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology)	SETD1A SETD1B	5.04e-05	2	210	2	DOID:0070417 (implicated_via_orthology)
Disease	lipid storage disease (biomarker_via_orthology)	SREBF1 SREBF2	5.04e-05	2	210	2	DOID:9455 (biomarker_via_orthology)
Disease	Pancreatic Endocrine Carcinoma	DAXX MEN1	1.51e-04	3	210	2	C1328479
Disease	Congenital myasthenic syndrome ib	DOK7 AGRN	1.51e-04	3	210	2	C1850792
Disease	Adrenocortical carcinoma	DAXX MEN1 ZNRF3	2.68e-04	18	210	3	C0206686
Disease	tea consumption measurement	SOX6 HECTD4 ZFHX3 CSMD1 SRRM3 SAMD4A	3.33e-04	129	210	6	EFO_0010091
Disease	Parkinson disease	RABEP2 SETD1A SP1 SREBF1 DGKQ ITPKB MUC19 KANSL1 FAM171A2	5.21e-04	321	210	9	MONDO_0005180
Disease	obsolete_red blood cell distribution width	TPP2 SP1 SETD1B GATA6 MAPKAPK5-AS1 DENND2B BMP6 ZNRF3 HECW2 OSBP2 HERC1 SOX6 TENT4A CLASP1 CARMIL1 HECTD4 SIK3 PARP10 KANSL1 RNF146 ASXL2	6.63e-04	1347	210	21	EFO_0005192
Disease	SLAM family member 8 measurement	IGKV2D-24 IGKV3-15	7.42e-04	6	210	2	EFO_0803079
Disease	bipolar disorder, schizophrenia, schizoaffective disorder	MAD1L1 CSMD1	7.42e-04	6	210	2	EFO_0005411, MONDO_0004985, MONDO_0005090
Disease	parental longevity	SNPH MAPKAPK5-AS1 FYCO1 SFI1 PRPF40B MAD1L1 HECTD4 OTUD7A CSMD1 SRRM3 HTT	8.84e-04	494	210	11	EFO_0007796
Disease	prostate cancer (is_marker_for)	SREBF2 DAXX BMP6 TCF3 SETD5 CDK13	9.07e-04	156	210	6	DOID:10283 (is_marker_for)
Disease	hepatocyte growth factor activator measurement	DOK7 HTT	1.03e-03	7	210	2	EFO_0008152
Disease	Intellectual Disability	SETD1A TRIO PEX6 CIC BPTF RHOBTB2 ATN1 SPECC1L KANSL1 HTT	1.45e-03	447	210	10	C3714756
Disease	interleukin 1 receptor-like 2 measurement	IGKV1-9 IGKV1-8	1.76e-03	9	210	2	EFO_0008169
Disease	Malignant tumor of prostate	MAD1L1 ZFHX3	1.76e-03	9	210	2	cv:C0376358
Disease	body surface area	BMP6 MFAP3 KCNE4 ACAN TICRR TENT4A ZBTB9 MSRB3 NCOR2 SETD5 ZFHX3 LTBP3	2.33e-03	643	210	12	EFO_0022196
Disease	Neuroendocrine Tumors	DAXX MEN1	2.66e-03	11	210	2	C0206754
Disease	interleukin-6 measurement, response to stimulus	CARMIL1 MUC16	2.66e-03	11	210	2	EFO_0004810, GO_0050896
Disease	bitter alcoholic beverage consumption measurement	CIC MAD1L1 SETD5 ZFHX3 CSMD1	2.68e-03	133	210	5	EFO_0010092
Disease	hypospadias	SP1 DENND2B ZFHX3	2.69e-03	39	210	3	EFO_0004209
Disease	Lenticulostriate Disorders	PDE8B SLC20A2	3.17e-03	12	210	2	C0750951
Disease	Extrapyramidal Disorders	PDE8B SLC20A2	3.17e-03	12	210	2	C0015371
Disease	motor neuron disease (implicated_via_orthology)	CHCHD10 KIF5C	3.17e-03	12	210	2	DOID:231 (implicated_via_orthology)
Disease	Hereditary hemochromatosis	BMP6 HJV	3.17e-03	12	210	2	C0392514
Disease	Hemochromatosis	BMP6 HJV	3.17e-03	12	210	2	C0018995
Disease	Basal Ganglia Diseases	PDE8B SLC20A2	3.17e-03	12	210	2	C0004782
Disease	vital capacity	UNC5B TRIM24 BMP6 ACAN MAD1L1 TRIM46 SOX6 KRT17 RANBP3 DOK7 SH2B1 MSRB3 NCOR2 KANSL1 ZFHX3 LTBP3 EN1 SAMD4A	3.34e-03	1236	210	18	EFO_0004312
Disease	Bladder Neoplasm	BPTF GLI1 TACC3 CREBBP ASXL2	3.34e-03	140	210	5	C0005695
Disease	orofacial cleft, sex interaction measurement	TNS3 ASCL2 OTUD7A ZFHX3	3.36e-03	86	210	4	EFO_0008343, MONDO_0000358
Disease	bipolar I disorder	STARD9 MAD1L1 KRT17 HTR6 PARP10	3.44e-03	141	210	5	EFO_0009963
Disease	Malignant neoplasm of urinary bladder	BPTF GLI1 TACC3 CREBBP ASXL2	3.44e-03	141	210	5	C0005684
Disease	grip strength measurement	BPTF MFAP3 MAD1L1 SH2B1 KANSL1 CADPS BRSK1 SAMD4A	3.75e-03	350	210	8	EFO_0006941
Disease	brain volume measurement	STK17A BMP6 FOXL1 SZT2 SH2B1 MSRB3 KANSL1 RNFT2 CADPS ZFHX3 ASXL2	3.76e-03	595	210	11	EFO_0006930
Disease	hepatocyte growth factor measurement	DOK7 OTUD7A HTT	3.80e-03	44	210	3	EFO_0006903
Disease	eye color	ITPKB CARMIL1 MUC16 CSMD1	3.95e-03	90	210	4	EFO_0003949
Disease	response to angiotensin-converting enzyme inhibitor, Cough	CLASP1 ASXL2 CSMD1	4.31e-03	46	210	3	EFO_0005325, HP_0012735
Disease	Hypodontia	EDA LTBP3	4.34e-03	14	210	2	C0020608
Disease	complement factor H measurement, protein binding measurement	FOXL1 LRRFIP1	4.34e-03	14	210	2	EFO_0008097, EFO_0010742
Disease	resting heart rate	SPEG SREBF1 SUN2 ASPH CSMD1	4.35e-03	149	210	5	EFO_0004351
Disease	mean reticulocyte volume	SETD1A SP1 STK17A TRO FBXO38 OSBP2 TACC3 SOX6 CLASP1 SPECC1L SH2B1 S1PR5 KANSL1	4.97e-03	799	210	13	EFO_0010701
Disease	urate measurement	MAPKAPK5-AS1 CHRM1 QRICH2 MEN1 TMEM11 HOXD1 GLI1 TRIM46 KRT17 CARMIL1 DOK7 HECTD4 ARHGAP17 SLC20A2	5.08e-03	895	210	14	EFO_0004531
Disease	multiple sclerosis (is_marker_for)	GLI1 ACAN IL21R	5.15e-03	49	210	3	DOID:2377 (is_marker_for)
Disease	Adenoid Cystic Carcinoma	KRT15 CREBBP KANSL1 EN1	5.74e-03	100	210	4	C0010606
Disease	Pancreatic Neoplasm	DAXX NR4A1 MEN1 ZNRF3	5.74e-03	100	210	4	C0030297
Disease	mean corpuscular hemoglobin concentration	SP1 SETD1B STK17A ZNRF3 HECW2 SEC16A TNS3 SOX6 TICRR ATN1 CLASP1 CARMIL1 HECTD4 SH2B1 SLC20A2 ASXL2	5.86e-03	1105	210	16	EFO_0004528
Disease	Malignant neoplasm of pancreas	DAXX NR4A1 MEN1 ZNRF3	6.16e-03	102	210	4	C0346647
Disease	triacylglycerol 52:2 measurement	SIK3 PTPRU CSMD1	7.10e-03	55	210	3	EFO_0010414

Protein segments in the cluster

Peptide	Gene	Start	Entry
GGGASALTSGIASSP	AGBL5	36	Q8NDL9
ASPFSGGSLVSSGLG	MLLT6	511	P55198
SSGLGGLSSRTFGPS	MLLT6	521	P55198
DSDAGSGGSSGLRLT	HTR6	381	P50406
DALPSGGAGSSLSQG	ARHGEF10	1246	O15013
GITEGDGSRTGSLPA	ASAP3	881	Q8TDY4
AGLSGRASGGAQSPL	ANKRD54	51	Q6NXT1
RDLGDGSSSTGSVGS	CCDC85B	176	Q15834
GGDVTAPRLGSFSGT	CSMD1	1861	Q96PZ7
SGSDGAESPSAARGG	CCNO	66	P22674
GAAESGALTASRSPG	ADRA2C	326	P18825
ASGTSPGLSAGATVG	CEACAM5	676	P06731
GRASPGGVSTSSSDG	ATN1	31	P54259
GSGGLEPLEGSSVAT	AGRN	1081	O00468
SELLRGGSGSSINPG	CREBBP	71	Q92793
GGGTLTSSVEGSAPG	SPECC1L	306	Q69YQ0
GSAVISEEGRSPGSG	DGKQ	366	P52824
AGAAGAGPRSLSSDS	ACAP3	596	Q96P50
AGPRSLSSDSGLGGS	ACAP3	601	Q96P50
GGAGAAPLGTLRASS	ABHD17A	46	Q96GS6
GSALGGQSSLPTSSG	CCDC142	376	Q17RM4
GSTSAGSSSPGARRE	ASPH	21	Q12797
SLSDASGSDGGRGPE	CEP170B	746	Q9Y4F5
PAGGASVSAGSRAVG	DENND2B	326	P78524
LGAAGPTSSGRAART	DENND6B	16	Q8NEG7
SESPGAGKGASGSTR	BPTF	761	Q12830
SGTSAADERGPGTRG	C1orf115	51	Q9H7X2
GSGGSPASSSGTQRR	CDK13	176	Q14004
SSEPHGARGSSSSGG	DAXX	41	Q9UER7
SGSGSESEPSSRGGS	DVL2	616	O14641
GSRPGSEDQSSGIGS	ARMCX4	1596	Q5H9R4
GPTLELAGTGSRGGT	ASXL2	726	Q76L83
GSDGRLAPGSAGSGS	ABHD8	126	Q96I13
ASSSPGRGGSSEPGS	ASCL2	146	Q99929
GDPSGVSGATVGRKS	C18orf25	126	Q96B23
ELAGRSAGGSSPEGG	RANBP3	91	Q9H6Z4
SRSSGAASSAPGGGD	RBM15	151	Q96T37
SSASGGGFRPGVDSL	RBM45	6	Q8IUH3
GGFTSLTSPEGTLSG	QRICH2	81	Q9H0J4
SGLGPDRTASGSGGT	QRICH2	111	Q9H0J4
GSGGTAHPSDGVSSR	QRICH2	121	Q9H0J4
SFSLGGGVGSSSSLP	RABEP2	236	Q9H5N1
SINGGDRPGGSSLSI	HJV	251	Q6ZVN8
ESSPGRGSSVSREGS	ARHGAP39	121	Q9C0H5
REGAAREPSGGSSGS	PRRX2	66	Q99811
SGVPDRFSGSGSGTD	IGKV2D-29	81	A0A075B6S2
TVAGTARGPEGGSTA	MEN1	526	O00255
TSTKARSGAPGGSEG	NR4A1	251	P22736
SSDTRVGAPATGSGT	CHIT1	276	Q13231
PTSGADTGTSDASGG	HECW2	576	Q9P2P5
SRTSEGSAGSAGLGG	CADPS	36	Q9ULU8
SGSREGSLSPARGDG	FBXO42	421	Q6P3S6
GSPGTLGGTSTSALT	MUC16	391	Q8WXI7
PGLRESSGSEGTSSG	MUC16	7831	Q8WXI7
RPGTASSSGGSIARG	NCOR2	1511	Q9Y618
RVDSRAPGSGTATSG	DCHS1	2871	Q96JQ0
QLEGGPGSTTISGRS	KIDINS220	1396	Q9ULH0
AASSSPLESRAAGGG	KCNE4	66	Q8WWG9
ASGVPDRFSGSGSGT	IGKV2D-40	81	P01614
SGVPDRFSGSGSGTD	IGKV2D-30	81	A0A075B6S6
LETGVPSRFSGSGSG	IGKV1D-33	76	P01593
LQSGVPSRFSGSGSG	IGKV1D-39	76	P04432
PATGDLLSTGTRSGS	KRT84	541	Q9NSB2
GPRATGLSGSQGSLT	LZTS2	166	Q9BRK4
GGLLGSGTRASPDSS	LZTS2	291	Q9BRK4
EGGSGLDISTSAPGS	MAD1L1	26	Q9Y6D9
LQSGVPSRFSGSGSG	IGKV1D-12	76	P01611
ATGIPDRFSGSGSGT	IGKV3D-20	76	A0A0C4DH25
AAGSGGSRAGTPLGT	FAM149A	36	A5PLN7
SSSGGVGGDVLSLAP	HOXD1	11	Q9GZZ0
ATLDGGRAGDSSGPS	HES2	126	Q9Y543
SEGPGSPDSSGSGTS	FYCO1	1231	Q9BQS8
SGVPSRFSGSGSGTD	IGKV6D-41	76	A0A0C4DH26
LQSGVPSRFSGSGSG	IGKV1D-43	76	A0A0B4J1Z2
SRGASRSSSPGAGGG	IQSEC2	206	Q5JU85
RSSSPGAGGGHSTST	IQSEC2	211	Q5JU85
SGVPDRFSGSGSGTD	IGKV2D-28	81	P01615
LQSGVPSRFSGSGSG	IGKV1D-37	76	P0DSN7
SGSTADSRPGAAVLG	HERC1	2806	Q15751
LQSGVPSRFSGSGSG	IGKV1D-8	76	A0A087WSZ0
LESGVPSRFSGSGSG	IGKV1D-13	76	A0A0B4J2D9
GEDSSSLGGGPSRRG	LMTK3	651	Q96Q04
GAGARDVGDGSSTSS	CCDC85C	196	A6NKD9
TTAGPVLGEGRGSDA	FBXW5	376	Q969U6
SGVPDRFSGSGAGTD	IGKV2D-24	81	A0A075B6R9
SGVPDRFSGSGSGTD	IGKV2D-26	81	A0A0A0MRZ7
VFGPDAGSSVGTGSS	MUC19	241	Q7Z5P9
PLDIGSGTTGTLSGG	MUC19	2541	Q7Z5P9
ATTGPSDEGSGTTGL	MUC19	2716	Q7Z5P9
TGLSPGVTGTSGLSA	MUC19	3706	Q7Z5P9
GLSAEATGTIGSSPG	MUC19	4026	Q7Z5P9
GPSAGVTRTTGLSAG	MUC19	4076	Q7Z5P9
GSEAPGGTSRKFSGT	MUC19	6366	Q7Z5P9
GATASPGGSATTRGR	MUC19	6606	Q7Z5P9
SATTGAPGSRTGTAG	MUC19	7006	Q7Z5P9
SGGSGATRAGLPRGT	MUC19	7176	Q7Z5P9
EATTFPGGSGTTRAG	MUC19	7341	Q7Z5P9
ATTFSGGSGSTRAGP	MUC19	7511	Q7Z5P9
DSLAPSRGRSGDSGG	PEX6	806	Q13608
RTELGSGSSAGSAAP	PDE8B	71	O95263
SSSAGSGSGDPSEGL	DCAF11	6	Q8TEB1
GRGGGSQDSSAETPL	GCGR	451	P47871
SRLSPGTDSSSNLGG	KANSL1	246	Q7Z3B3
LQSGVPSRFSGSGSG	IGKV1D-17	76	A0A075B6S4
AGGPTSDISTGSSVG	LHX4	356	Q969G2
GSVGGSTGPSAAASF	KIF26A	291	Q9ULI4
ARGGGTSPTAASSLD	GLI1	596	P08151
STFGGGSTRGGSLLA	KRT15	11	P19012
TGIPARFSGSGSGTE	IGKV3D-15	76	A0A087WSY6
KSPGGASGGSTRVSA	KRT35	16	Q92764
GTASPGGGARRASAS	OTUD7A	741	Q8TE49
RATATVPDSSGGGGG	GGN	551	Q86UU5
TLTALDGGSPSRSGT	PCDHB10	211	Q9UN67
PGGSGSSATRSLFGG	HECTD4	146	Q9Y4D8
GLSLSLSPGASGSSG	EN1	26	Q05925
SGSSGSGSDGDSVPV	EN1	36	Q05925
LQGSRPGSESSSGVG	OSBP2	101	Q969R2
EGTGSEASSTRRGGS	LTB4R	306	Q15722
GRSNSPGGDSDDGSL	MFAP3	291	P55082
LDPGTRATGGSLSTG	MTMR4	261	Q9NYA4
SSSSSASLGRPGGGR	TENT4A	111	Q5XG87
TSAVGDLSGLPSGGE	ACAN	1461	P16112
SGLPSGGEGLETSAS	ACAN	1546	P16112
TFPGRGSGAGVGTTL	INO80E	186	Q8NBZ0
GGVTEASSLLGGSPR	PTPRU	841	Q92729
GGGARSTDASLDSGV	FAM171A2	676	A8MVW0
GSGSGATGEDRRGSS	FBXO38	836	Q6PIJ6
SSSSSCSRGGERGPG	GATA6	41	Q92908
SRLGGSGTPGTSGTL	EDA	76	Q92838
TDAAGSRGGSDGTPR	ARAF	241	P10398
GELAASSGVSTPGSA	HTT	476	P42858
GGGSSRTSCRLSGGL	KRT17	21	Q04695
GTRSPGAAGLTSRDS	HS1BP3	136	Q53T59
ESGAGGGRRATISSP	BORCS6	186	Q96GS4
SSGGTSPIRARAGSE	C20orf202	81	A1L168
DITLGSRSAPSGGGA	FCRL1	246	Q96LA6
GSALTGAFSGGSSEP	CHCHD10	66	Q8WYQ3
EGLTGTGTGPSRAEA	DNAJB2	71	P25686
SLEGSGISSGSSPRV	CCDC166	376	P0CW27
GSGSGGASPLTSAQD	BMP6	191	P22004
PGKGGGSSSSSERSQ	CHRM1	231	P11229
AGDEARGGGSPTSKT	BRSK1	461	Q8TDC3
TGGSGPGLSRTGALS	LTBP3	151	Q9NS15
DPGAGSASAGGSRLA	MAPKAPK5-AS1	61	Q8N8E1
GSPGGSGSALSAQST	DENND4B	1016	O75064
EAGSGAGGSGPAISR	FOXL1	171	Q12952
LESGVPSRFSGSGSG	IGKV1-5	76	P01602
LQSGVPSRFSGSGSG	IGKV1-6	76	A0A0C4DH72
SGVPSRFSGSGSGTD	IGKV1-8	76	A0A0C4DH67
LQSGVPSRFSGSGSG	IGKV1-9	76	A0A0C4DH69
LQSGVPSRFSGSGSG	IGKV1-12	76	A0A0C4DH73
LESGVPSRFSGSGSG	IGKV1-13	76	P0DP09
LQSGVPSRFSGSGSG	IGKV1-17	76	P01599
LQSGVPSRFSGSGSG	IGKV1-27	76	A0A075B6S5
LETGVPSRFSGSGSG	IGKV1-33	76	P01594
LQSGVPSRFSGSGSG	IGKV1-37	76	A0A075B6S9
LQSGVPSRFSGSGSG	IGKV1-39	76	P01597
SGVPDRFSGSGAGTD	IGKV2-24	81	A0A0C4DH68
SGVPDRFSGSGSGTD	IGKV2-28	81	A0A075B6P5
SGVPDRFSGSGSGTD	IGKV2-29	81	A2NJV5
SGVPDRFSGSGSGTD	IGKV2-30	81	P06310
ASGVPDRFSGSGSGT	IGKV2-40	81	A0A087WW87
TGIPARFSGSGSGTD	IGKV3-11	76	P04433
TGIPARFSGSGSGTE	IGKV3-15	76	P01624
ATGIPDRFSGSGSGT	IGKV3-20	76	P01619
ESGVPDRFSGSGSGT	IGKV4-1	81	P06312
SSPALSGVERSDGGG	CARMIL1	1196	Q5VZK9
GGRSPGGVSESEAGS	IL21R	466	Q9HBE5
AGRPGSGGDDRSLSS	DOK7	251	Q18PE1
AAVPASGTGGESSGL	GOLGA8B	406	A8MQT2
DGLDTSGSTGSPGAP	S1PR5	371	Q9H228
PLTGAAGETLGTSEG	SLC20A2	286	Q08357
LGGTSSRRGSGDTSI	LRRFIP1	111	Q32MZ4
NSFGPSGGLREGSLS	PTPN13	1231	Q12923
GSGEEPGQSGASLRT	PARP10	296	Q53GL7
TLTALDGGSPSRSGT	PCDHB9	211	Q9Y5E1
GVGLDTSVASPSSGG	MEIS3P1	136	A6NDR6
SLSDSLSSRGVGGAG	NYX	441	Q9GZU5
GASGLTPASGGSDQS	FOXN4	461	Q96NZ1
SFPSSLVLGSSAGGG	RNFT2	71	Q96EX2
TSGSGVRGEAGPASG	RTL1	36	A6NKG5
GSSAGSPGEASGLIL	SZT2	3226	Q5T011
DFSATRAGPGLSTAG	SFI1	1131	A8K8P3
SGNGTPRGGSDLSVS	RGMB	411	Q6NW40
AGTVGRGLVSDGTSP	SH2B1	206	Q9NRF2
ARSSSDSGSGRGAPG	SRRM3	426	A6NNA2
GASSNAGLTGRDGPT	TRIM46	666	Q7Z4K8
FGSGSSSESGPGALA	TACC3	136	Q9Y6A5
EGRTITAGAGSLAPG	TDRD6	101	O60522
GLAASSRASLDPGGG	TOGARAM2	136	Q6ZUX3
PTAVHAIRGGGGSSS	KIF5C	936	O60282
SSSGGGTVPSSAGIL	ARHGAP17	551	Q68EM7
ETSGTDSGRKGGPSL	ITPKB	211	P27987
GSGPAGLRASTSDGI	RHOBTB2	356	Q9BYZ6
ASPARSGGGSGFLSN	SNX33	91	Q8WV41
GPTSETGFPSRSGDG	SETD5	951	Q9C0A6
AGSSGRGISISPSAG	SIK3	826	Q9Y2K2
ASPGGLDRGTTSTLG	SLC38A7	41	Q9NVC3
SDRSGTDRSVAGGGT	RNF146	326	Q9NTX7
GRSITDKTSGGPSSG	SLC41A2	6	Q96JW4
GLSAGCGSGSSSVTP	SETD1B	231	Q9UPS6
DSGILSSPSGTSSGG	STARD9	311	Q9P2P6
SSGTAEGGSGVASPA	MSRB3	171	Q8IXL7
GTGESAGGSPARSLT	SNPH	196	O15079
VGTLPLDSGAGSEGS	SP1	721	P08047
LDSGAGSEGSGTATP	SP1	726	P08047
EGDRSLGSVSPSSSG	TNS3	1106	Q68CZ2
DGDGRTSPLGGARSS	PROB1	771	E7EW31
LGARDTGSEVPSGSG	SETD1A	521	O15047
RPGGKTGSGGVASSS	SF3A2	6	Q15428
GSSPGATSGSGRAGR	STK17A	11	Q9UEE5
ATSGSGRAGRGLSGP	STK17A	16	Q9UEE5
RSLSGSPKGGGSSLE	ARHGAP22	436	Q7Z5H3
ISGGLGGALSGASRS	SHANK1	2061	Q9Y566
SPIGGSLGRGSSLDI	SOX6	466	P35712
RGSGSGGSGSDSEPD	SREBF1	446	P36956
VAPGGSSESSSGRAA	CIC	1301	Q96RK0
SRAAGSGSTPGAGSK	LINC00612	81	Q8N6U2
GAGSRSSSPGKLLGS	CLASP1	681	Q7Z460
GSSRGSSEEGPSGLP	INPP5J	931	Q15735
VGSRGSSGSSSKPAG	TRIM24	691	O15164
AAEGSSGPAGLTLGR	SEPHS2	16	Q99611
AGSSSGRGEVGADLP	TICRR	1696	Q7Z2Z1
SGSDGSSTRTGHGPL	ZC3H6	641	P61129
RVGSSGGSGPGDSYS	ZBTB7B	241	O15156
PGSSGGSARERVSLS	TMEM11	11	P17152
DGGASSTGSRDLGAA	MINPP1	116	Q9UNW1
GTGGSESSRASGLVG	SUN2	106	Q9UH99
GGDSGENTSLSGIPT	SEC16A	876	O15027
GESSEGGSSARGSPV	SPEG	2436	Q15772
GGLSTSDGFGSRPNA	TRO	1311	Q12816
TTEPDATGGGSGSLA	SOWAHA	446	Q2M3V2
SSLSSSTFLGPGLGG	TCF3	86	P15923
SLLGSRGTTAGSSGD	TCF3	316	P15923
GAADGALGPGSREST	PLPPR3	671	Q6T4P5
TPGTGSRNSGSGVAG	SOGA3	226	Q5TF21
GTVTNPGGSGTSSRL	STXBP2	446	Q15833
GSGRSVLSFESGSGG	SREBF2	516	Q12772
SPGAESLRVGSSAGS	TMEM79	41	Q9BSE2
SRGPSADGALGVSIS	TPP2	411	P29144
SVESGGAALGGRGSP	PRPF40B	751	Q6NWY9
GPNALGSGGSRSSSS	TPRXL	26	Q17RH7
GLAGASGRSSEEPGV	PHLDB1	656	Q86UU1
SSSTTGSGPGLADGA	UNC5B	486	Q8IZJ1
ADLSDGSSGGSSIGP	PRAG1	571	Q86YV5
GTKTSAREGGPGSSL	PLEKHH1	296	Q9ULM0
LETSGGGISARGGNS	ZBTB9	141	Q96C00
RASEAGGSGSSGRGP	ZNRF3	606	Q9ULT6
AGSPRASLAGSDGGG	WTIP	86	A6NIX2
SQGPSSTLGLERGAG	TRUB2	316	O95900
ASGISGRRSTAGDGS	WDR87	1226	Q6ZQQ6
SSSARPSGSGQEVGG	XIRP1	1591	Q702N8
GSGATGSRPEGLAAV	ZNF185	351	O15231
ATGATATPSAGASGG	SAMD4A	456	Q9UPU9
GSASSSASLRVLGPG	TRIO	2766	O75962
SREGSESGPGPSSGS	ZNF541	441	Q9H0D2
ASVGLSEGPAGSRSG	YRDC	16	Q86U90
LGSGLGLSPGTSSGR	ZNF358	446	Q9NW07
SGSAGKSGDSGDRPG	ZFHX3	2931	Q15911
GRGSPSGGSTAEASD	KIAA1522	401	Q9P206
LQSGVPSRFSGSGSG	IGKV1D-16	76	P01601
GGSRSPAGGESATVA	NAA30	51	Q147X3